Multiple Myeloma Research Consortium
4 clinical trials · Sponsor
◉ Watch Multiple Myeloma Research Consortium
| Record | Firm | Date |
|---|---|---|
| Horizon Two: HR NDMM (MMRC-100) (NCT07053436) | Multiple Myeloma Research Consortium | 2026-04-30 |
| MMRC Horizon One: RRMM (MMRC-099) (NCT06171685) | Multiple Myeloma Research Consortium | 2024-11-17 |
| Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT (NCT04150965) | Multiple Myeloma Research Consortium | 2020-07-10 |
| Myeloma-Developing Regimens Using Genomics (MyDRUG) (NCT03732703) | Multiple Myeloma Research Consortium | 2019-04-01 |
Track Multiple Myeloma Research Consortium automatically
Every clearance here is in the API, with alerts when new ones post.